Shares of Viela Bio (NASDAQ: VIE) have rocketed on Monday after revealing that the company will be acquired by my Horizon Therapeutics (NASDAQ: HZNP).
Horizon Therapeutics will pay $53 in cash in a deal worth approximately $3.05 billion, with the transaction is expected to close by the end of the first quarter of 2021.
Viela Bio shares have rocketed, currently trading at 52.89 up 52.51% on the day.
Ready to put what you’ve learned into practice?
Try IG’s platform with £10,000 in virtual funds and practise trading
without putting your own money at risk.
Try IG with a demo account →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Learn the markets with IG Academy
Build your knowledge with IG Academy educational content, then use a
demo account to practise what you’ve learned on the IG platform.
Explore IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
See how trading works before risking real money
IG’s demo gives you access to thousands of markets and £10,000 in
virtual funds, so you can explore the platform and test your ideas first.
Open an IG demo →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Turn trading theory into practical experience
Learn with IG Academy, explore charts and market tools, and practise
strategies in a simulated trading environment before going live.
Start practising with IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Ready to take your learning further?
IG combines market education, analysis and an established trading platform,
giving you the tools to keep learning as you develop your trading skills.
Discover IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
“We are pleased that Horizon recognizes the value of our robust R&D pipeline, our commercial medicine UPLIZNA, which is an important treatment option for patients with NMOSD, and our talented team,” said Bing Yao, chairman and CEO of Viela Bio, Inc.
Horizon said the acquisition expands its pipeline to accelerate growth over the long-term adding freelance research and clinical development capabilities along with its mid-stage biologics pipeline.
Horizon will finance the transaction through $1.3 billion of external debt, along with cash on hand. It has also put in place fully committed financing with Citigroup Global Markets and Morgan Stanley Senior Funding.
AstraZeneca will also divest its shareholding in Viela, after retaining a 26.7% stake when it sold the business in 2018 and could make up to $780 million from the deal.
